OverviewSuggest Edit

    HTL is a biotechnology company specializing in the design, development, and production of pharmaceutical-grade hyaluronic acid and other functional biopolymers. It serves the pharmaceutical and medical device industries

    Latest Updates

    Employees (est.) (Nov 2021)95(+4%)
    Cybersecurity ratingAMore
    Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
    Banner background

    HTL Financials and Metrics

    Summary Metrics

    Founding Date


    HTL Cybersecurity Score

    Cybersecurity ratingPremium dataset



    SecurityScorecard logo

    HTL Online and Social Media Presence

    Embed Graph

    HTL News and Updates

    Terasaki Institute for Biomedical Innovation and HTL Biotechnology Announce Memorandum of Understanding for Research in Translational Biomaterials

    LOS ANGELES, May 7, 2021 /PRNewswire/ -- The Terasaki Institute for Biomedical Innovation (TIBI), a research institute at the frontier of personalized and precision medicine, and HTL Biotechnology, the world leader in using hyaluronic acid and other biopolymers for biotechnology...

    HTL Frequently Asked Questions

    • When was HTL founded?

      HTL was founded in 1992.

    • How many employees does HTL have?

      HTL has 95 employees.

    • Who are HTL competitors?

      Competitors of HTL include Tradichem, USV Peptides and Procos.